Publications by Anders P. Jørgensen
36 publications found
Original articles
Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease - a cross-sectional study
Eur J Endocrinol, 189 (4), 438-447
DOI 10.1093/ejendo/lvad136, PubMed 37807083
Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies
iScience, 26 (7), 107084
DOI 10.1016/j.isci.2023.107084, PubMed 37346050
Plasma-Metanephrines in Patients with Autoimmune Addison's Disease with and without Residual Adrenocortical Function
J Clin Med, 12 (10)
DOI 10.3390/jcm12103602, PubMed 37240708
A polygenic risk score to help discriminate primary adrenal insufficiency of different etiologies
J Intern Med, 294 (1), 96-109
DOI 10.1111/joim.13649, PubMed 37151110
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours
Pituitary, 26 (2), 227-236
DOI 10.1007/s11102-023-01310-x, PubMed 36952069
Autoimmune Thyroid Disorders in Autoimmune Addison Disease
J Clin Endocrinol Metab, 107 (6), e2331-e2338
DOI 10.1210/clinem/dgac089, PubMed 35226748
Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome
J Clin Endocrinol Metab, 106 (9), e3634-e3643
DOI 10.1210/clinem/dgab300, PubMed 33950234
GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility
Nat Commun, 12 (1), 959
DOI 10.1038/s41467-021-21015-8, PubMed 33574239
TGFBR3L-An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue
Cancers (Basel), 13 (1)
DOI 10.3390/cancers13010114, PubMed 33396509
[The trouble with medical coding]
Tidsskr Nor Laegeforen, 140 (14)
DOI 10.4045/tidsskr.20.0541, PubMed 33070589
FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors
J Clin Endocrinol Metab, 105 (8), 2587-94
DOI 10.1210/clinem/dgaa281, PubMed 32421791
Residual Corticosteroid Production in Autoimmune Addison Disease
J Clin Endocrinol Metab, 105 (7), 2430-41
DOI 10.1210/clinem/dgaa256, PubMed 32392298
[Glucocorticoids with a side effect]
Tidsskr Nor Laegeforen, 140 (3)
DOI 10.4045/tidsskr.19.0495, PubMed 32105044
Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma
Acta Neurochir (Wien), 162 (4), 845-852
DOI 10.1007/s00701-019-04068-z, PubMed 31907611
[Not Available]
Tidsskr Nor Laegeforen, 137 (23-24)
DOI 10.4045/tidsskr.17.0848, PubMed 29231650
A woman in her 50s with chronic fatigue syndrome, sepsis and hyponatraemia
Tidsskr Nor Laegeforen, 137 (5), 372-377
DOI 10.4045/tidsskr.16.0896, PubMed 28272569
A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1
J Clin Endocrinol Metab, 101 (8), 2975-83
DOI 10.1210/jc.2016-1821, PubMed 27253668
Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment
J Clin Endocrinol Metab, 100 (2), 736-43
DOI 10.1210/jc.2014-2912, PubMed 25459913
Dual-energy X-ray absorptiometry is a valid method to estimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone
J Clin Endocrinol Metab, 99 (9), E1727-31
DOI 10.1210/jc.2014-2059, PubMed 24955611
Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study
Growth Horm IGF Res, 24 (1), 16-21
DOI 10.1016/j.ghir.2013.11.002, PubMed 24360789
[New steroid card for adrenal insufficiency]
Tidsskr Nor Laegeforen, 132 (18), 2043-4
DOI 10.4045/tidsskr.12.0946, PubMed 23038193
Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment
Eur J Endocrinol, 165 (3), 393-400
DOI 10.1530/EJE-11-0442, PubMed 21653735
Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency
Clin Endocrinol (Oxf), 74 (1), 60-6
DOI 10.1111/j.1365-2265.2010.03884.x, PubMed 21039720
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
DOI 10.1111/j.1753-0407.2009.00031.x, PubMed 20923537
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
Vasc Health Risk Manag, 5 (1), 121-8
PubMed 19436668
[Glitazone treatment of type 2 diabetes mellitus]
Tidsskr Nor Laegeforen, 126 (15), 1928-30
PubMed 16915317
Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
Eur J Endocrinol, 154 (4), 537-43
DOI 10.1530/eje.1.02125, PubMed 16556716
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
Eur J Endocrinol, 153 (3), 379-87
DOI 10.1530/eje.1.01971, PubMed 16131600
Other articles
Endocrine Workup for Primary Aldosteronism Should Include Adrenal Venous Sampling in Young Patients
J Clin Endocrinol Metab, 106 (7), e2828-e2829
DOI 10.1210/clinem/dgab142, PubMed 33687060
Medical coding for discomfort
Tidsskr. Nor. Laegeforen., 140 (14), 1426-1427
Glucocorticoids with bitter taste
Tidsskr. Nor. Laegeforen., 140 (3), 277
ENDOCRINOLOGY
Tidsskr. Nor. Laegeforen., 137 (23-24), 1955
[Can Health-Norway be united into one kingdom?]
Tidsskr Nor Laegeforen, 136 (17), 1432
DOI 10.4045/tidsskr.16.0618, PubMed 27686201
[Think holistically, think cooperation]
Tidsskr Nor Laegeforen, 133 (21), 2275
DOI 10.4045/tidsskr.13.1075, PubMed 24226337
Bone: Growth hormone replacement--implications for bone health
Nat Rev Endocrinol, 8 (6), 325-6
DOI 10.1038/nrendo.2012.50, PubMed 22473331
[The simplest can be the best]
Tidsskr Nor Laegeforen, 131 (20), 2012
DOI 10.4045/tidsskr.11.1081, PubMed 22016129